"My nurse practitioner made it clear to me that this drug shouldn't just be a crutch that you rely on to lose weight," Schorr said
Yes, pharmaceutical companies are developing additional dual and triple agonist medications
They are marketed as nutritional supplements or drops and may make fraudulent use of the logos of regulatory authorities such as Swissmedic and carry invented quality marks with the aim of deliberately deceiving consumers
Criminal counterfeiters and questionable suppliers are deliberately exploiting this trend by promoting these products sometimes very aggressively on social media, websites or via direct advertising in particular
[DOI] [PubMed] [Google Scholar] 290.Varady K.A., Runchey M.C., Reutrakul S., Vidmar A.P., Chow L.S
Today, tirzepatide carries similar or identical warnings against severe side effects on its FDA labels